Search
Search Results
##search.searchResults.foundPlural##
-
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
913PDF: 629HTML: 180 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1670PDF: 660HTML: 657 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1763PDF: 691HTML: 181 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1320PDF: 828HTML: 1370Table: 153 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1093PDF: 1100HTML: 403 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
3943PDF: 1618HTML: 1081 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4465PDF: 1437HTML: 2191Untitled: 153Untitled: 170Untitled: 180Untitled: 155Untitled: 148 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2077PDF: 1488HTML: 443 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2285PDF: 964HTML: 82 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2397PDF: 720HTML: 5152 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
2916PDF: 1026HTML: 1651 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
1906PDF: 1376HTML: 204 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3689PDF: 1794HTML: 5114Table 1: 156 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2373PDF: 1029HTML: 111 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1111PDF: 427HTML: 18517Figure 1: 122Figure 2: 112Figure 3: 136Figure 4: 162Figure 5: 136 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
2838PDF: 1831HTML: 7420 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2304PDF: 796HTML: 2081 -
PROPHYLAXIS OF MALARIA
2845PDF: 940HTML: 17737Figures SChwartz: 125 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
3888PDF: 1132HTML: 1935Table 1: 141 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3361PDF: 791HTML: 6674 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1266PDF: 427HTML: 174 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3520PDF: 1133HTML: 1621Untitled: 113 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4114PDF: 1498HTML: 2974Tables and Images: 163 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
3984PDF: 1393HTML: 1505Untitled: 185







